Additionally, phosphorylated NF-κB and p38 MAPK protein expression were remarkable decreased in orally administrated with MccJ25 after LPS infection compared with the LPS-treated mice group (P < 0.05) (Figure 7I). The gene discussed is NFKB1; the disease is infection.